CoronaVac efficacy data from Turkey - Authors' reply.

Tanriover, Mine Durusu; Doganay, Hamdi Levent; Unal, Serhat; Akova, Murat

Tanriover, Mine Durusu; Doganay, Hamdi Levent; Unal, Serhat; Akova, Murat.

Afiliação

Tanriover MD; Department of Internal Medicine, Hacettepe University School of Medicine, Ankara 06230, Turkey; Hacettepe University Vaccine Institute, Ankara, Turkey.
Doganay HL; Department of Gastroenterology, Turkish Republic Ministry of Health, Istanbul Provincial Health Directorate, University of Health Sciences Istanbul Umraniye Training and Research Hospital, Istanbul, Turkey.
Unal S; Department of Infectious Diseases and Clinical Microbiology, Hacettepe University School of Medicine, Ankara 06230, Turkey; Hacettepe University Vaccine Institute, Ankara, Turkey.
Akova M; Department of Infectious Diseases and Clinical Microbiology, Hacettepe University School of Medicine, Ankara 06230, Turkey; Hacettepe University Vaccine Institute, Ankara, Turkey. Electronic address: makova@hacettepe.edu.tr.

Lancet ; 398(10314): 1874, 2021 11 20.

Article em En | MEDLINE | ID: mdl-34801106

Assuntos

Anticorpos Neutralizantes; Anticorpos Antivirais; Humanos; Turquia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Anticorpos Antivirais Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google